Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 08:30 ET | Source: K Wave Media

K Wave Media Announces Strategic Transformation into K-Culture Consumer, IP and Digital Asset Platform & Name Change Plan

NEW YORK and SEOUL, South Korea, April 07, 2026 (GLOBE NEWSWIRE) -- K Wave Media (“K-Wave” or the “Company”) today issued a CEO vision letter detailing its strategic transformation into a...
April 07, 2026 07:45 ET | Source: Wrap Technologies, Inc.

Galveston Police Department Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription, Supported by In-Person Training as Part of Broader NLR Strategy

Galveston Police Adopts Non-Lethal Response Solutions with Purchase of BolaWrap® Devices and WrapTactics™ Subscription as Part of Broader NLR Strategy
April 07, 2026 07:30 ET | Source: WW International Inc.

Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced that it...
April 07, 2026 07:03 ET | Source: Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

~ University of Arizona Cancer Center Initiating Study to Explore Use of PEDMARK® in AYA & Adult Patients with Solid Tumors Receiving Cisplatin ~ ~ This New Study and Other Independent,...
April 07, 2026 04:00 ET | Source: Wolters Kluwer N.V.

Wolters Kluwer accelerates AI leadership with AI Center of Excellence and “FAB” platform

Wolters Kluwer announced continued momentum from its AI Center of Excellence and proprietary Foundation and Beyond (“FAB”) AI enablement platform.
April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale

Des études de phase 2 sur le lunsekimig ont atteint les critères d’évaluation principaux et secondaires clés dans deux maladies respiratoires
April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

Phase 2 studies of lunsekimig, a novel bispecific nanobody, met primary and key secondary endpoints in two chronic respiratory conditions.
April 06, 2026 16:25 ET | Source: Wabash National Corporation

Wabash Schedules First Quarter 2026 Earnings Conference Call

LAFAYETTE, Ind., April 06, 2026 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) today announced that it will webcast its quarterly earnings conference call to review and discuss its financial results for the...
April 06, 2026 13:49 ET | Source: WellSpan Health

WellSpan Health announces President & CEO Roxanna Gapstur’s planned retirement

York, Pa., April 06, 2026 (GLOBE NEWSWIRE) -- The WellSpan Health Board of Directors today announced that Roxanna Gapstur, Ph.D., R.N., president and chief executive officer, has shared her plans to...
April 06, 2026 12:00 ET | Source: Glancy Prongay Wolke & Rotter LLP

Deadline Alert: Coty Inc. (COTY) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES, April 06, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 22, 2026 deadline to file a lead plaintiff motion in the class action...